INTRODUCTION
Carbon-14 ( 14 C) is a radioactive isotope of carbon that is produced by nitrogen-14 ( 14 C has long half-life (t 1/2 = 5730 years), and it decays to nonradioactive 14 N through radioactive β-decay, which emits an electron and an antineutrino (2-6). Due to very low natural abundance and long half-life, 14 C is an ideal tracer for environmental as well as in vivo human or animal studies.
Traditionally, 14 C has been measured using decay counters such as a liquid scintillation counter (LSC). LSC usually requires a gram-sized carbon sample and long measuring time (>48 h) to obtain a statistical precision of e1% (4, 5). Conventional mass spectrometry (MS) was also an alternative technique to detect various isotopes. However, isotopes such as 14 C with rare natural abundance cannot be detected for lack of sensitivity of conventional MS (detection limit of 14 C/ 12 C ratio using MS, g1 Â 10 Accelerator mass spectrometry (AMS) is the ultimate technique to measure long-lived isotopes such as 14 C due to extremely high selectivity and sensitivity. AMS was first developed in the early 1930s (10), but it was not used for 14 C measurement until 1977 due to atomic isobar interference with 14 14 C, 26 Al, 41 Ca, ) level, making AMS 1000 times more sensitive than LSC (3, 5, 14) . AMS required a milligram or less of carbon (emg of C). Sample mass for AMS was 1000 times less than that for LSC (3-5, 8, 14) . Furthermore, AMS achieved a precision of ≈1% in 5-10 min (3-6). The great efficiency and sensitivity made AMS the ultimate tool for quantifying metabolic behaviors of food components, nutrients, and biopharmaceuticals using a 14 C tracer. Biological/biomedical applications using AMS were first suggested ≈30 years ago (15), and these applications began in earnest *Author to whom correspondence should be addressed [e-mail ajclifford@ucdavis.edu; telephone (530) 752-3376; fax (530) 752-8966].
N (11)
in the early 1990s (16) . In vivo in human or in vivo in animal dynamic and kinetic behaviors, absorption, distribution, metabolism, elimination (ADME) of food component, nutrients (17) (18) (19) (20) (21) , or environmental chemicals (22-24) using 14 C-AMS have been reported during the past two decades.
For biological/biomedical 14 C-AMS applications, very small amounts of 14 C-labeled compound were administered to humans and commonly called microdosing in drug development studies. The U.S. Food and Drug Administration (25) and European Medicines Agency (26) defined microdosing as only 1% of a therapeutic dose or e100 μg/person. Because pharmacokinetics (PK) with microdosing was ≈70% equivalent of a PK with therapeutic dose (27) , microdosing combined with AMS enabled physiological-based (steady-state) kinetic/dynamic behavior study of food components or nutrients to be conducted. Thus, AMS methods led to better understanding of in vivo in human metabolism of food components or nutrients (14) . The combination of microdosing and AMS also minimized the risk of toxicity, cost, time, and labor, especially for new drug development in the pharmaceutical industry (4).
The typical radiation exposure experienced during a 4 h airplane ride at 37000 feet altitude was 20 μSv (28). The radiation exposure of 20 μSv was considered to be an acceptable level of exposure in the United States, so 20 μSv is used as a reference level. Human radiation exposure calculation from the administered 14 C-labeled food components or nutrients is an integral part of protocols for biological/biomedical AMS applications. Therefore, the present study reported a practical and complete method for calculating the 14 C radiation exposure during the conduct of our four prior studies (18) (19) (20) (21) . The method took into account 14 C dose level, body mass, biological half-life of 14 C-labeled nutrients, tissue weighting factor (radiation exposure in an organ and/or tissue relative to that of the whole body mass in dimensionless multiplicative factor), and fractional nutrient content in each organ or tissue.
MATERIALS AND METHODS
Subject Selection. Human subjects who were healthy nonsmoking adults aged 20-60 years with a BMI of 20-37.5 kg/m 2 were recruited ( (18) (19) (20) (21) . Nutrients were chemically (β-carotene, R-tocopherol) or biologically (lutein, folic acid) labeled with 14 C. 14 C-Nutrients (36-100 nCi) were orally administered to human subjects with breakfast. Oral dose administration was also approved by the UCD and LLNL Human Subjects Review Committees prior to 14 C-nutrient studies (18) (19) (20) (21) . A small ratio (mol/mol) of 14 C-nutrient dose to Recommend Dietary Allowances (RDA) was necessary for the physiologicalbased (steady-state) 14 C-tracer study. The RDAs of β-carotene and lutein were not decided yet, so U.S. average intake (AI) was considered for steady-state 14 C-tracer study. Sample Collections. Prior to 14 C-nutrient dose, fasting plasma, urine, and feces were collected for 14 C baselines of each human subject. Serial plasmas, urines, and feces were collected over time since 14 C-nutrient dose (18) (19) (20) (21) . A predose baseline blood sample was collected. Additional blood samples were usually collected at every 0.5 h interval from 0 to 12 h, hourly from 12 to 16 h, and then at 24 and 36 h after 14 C-nutrient dose. Subsequent blood samples were collected daily from 2 to 7 days, every other day from 7 to 14 days, then weekly, biweekly, and/or monthly for the remainder of the study. In addition, prior to dosing 14 C-nutrient in each study, a complete collection of feces and urine was also taken to establish baseline values. Serial collections of feces and urine usually continued for 14 and 21 days, respectively, after the day of 14 C-nutrient dosing. Durations of β-carotene, lutein, R-tocopherol, and folate studies were 5, 3, 3, and 6 months, respectively. When 100 nCi of 14 C was dosed to the 70 kg human subject, collected samples had 0.0014 nCi of 14 C/g, a level considered to be nonradioactive according to the U.S. Code of Federal Regulations, Title 10, Section 20.2005, 1991 (cutoff, e50 nCi/g or 1 μCi/year), enabling waste to be disposed of as nonradioactive waste.
Graphitization. All reagents and materials for sample preparation (18) (19) (20) (21) and graphitization/ 14 C-AMS measurement (29-31) were previously described and are summarized below. High-throughput (HT) 14 C-AMS applications usually required 1 mg of C sample, so carbon content in the sample of interest was measured (32) . Prior to 14 C-AMS measurement, samples of interest were converted to elemental carbon, usually graphite-like materials. Sample preparation (often called graphitization) consisted of oxidation (combustion: sample f CO 2 ) and reduction (graphitization: CO 2 f C graphite-like materials ) steps. We have previously used three different graphitization methods for β-carotene (31), lutein (31), R-tocopherol (29, 30) , and folic acid (29) studies. Recently, we optimized our graphitization method (maximum 270 samples/day) for accurate and precise HT-14 C-AMS measurement (33) . More information about graphitization is included in the Supporting Information (Figure 1 ; Table 1 ).
14 C-AMS Measurement. One million voltage AMS at the Center for AMS at LLNL (see Supporting Information, Figure 2 ) measured (40) a The study design was a test and retest in one subject. b SA was determined by using a mix of 0.5 nmol of 14 C-folic acid and 79.5 nmol of nonlabeled cold folic acid. c The Institute of Medicine at the National Academy of Sciences did not establish a Tolerable Upper Intake Level (UL) for carotenoids when it reviewed these compounds in 2000.
14 C/ 13 C ratios from graphitized solid samples. Measured 14 C/ 13 C ratios of samples were normalized with one of the popular AMS standards such as oxalic acid, NIST SRM 4990B/4990C, or sucrose, IAEA-C6 (34, 35). Finally, 14 C level in samples was defined as "Modern or Fraction Modern (F m )". A current/natural 14 C level in living organisms is about 1.1 F m (= 107.6 amol of 14 C/mg of C, 6.72 fCi/mg of C, or 14.92 dpm/g of C) (30, 36) .
Human Radiation Exposure Calculation from 14 C Dose. Radiation exposure from 14 C-labeled nutrient was calculated (3) as
where E d is energy deposition per decay as joules (8.3 fJ/decay), M d is the affected mass (kg), dose is the amount of radioactivity in dpm, τ bio is the biological mean-life of 14 C-labeled compound in minutes or seconds, W T is tissue weighting factor (radiation exposure in an organ and/or tissue relative to that of the whole body (WB) in dimensionless multiplicative factor (see Supporting Information, Table 2 ) (37) , and FN is the fractional nutrient content in each organ or tissue (see Supporting Information, Table 2 ).
Radiation exposure was calculated previously without considering W T and the FN (3). The formula (eq 1) for radiation exposure estimation was modified by considering W T for each organ as well as different FN. The formula (eq 1) can more completely calculate radiation exposure over the biological mean-life. For example, if 100 nCi of 14 C-β-carotene, which had the τ bio of 36.1 days (equals to 51984 min), was administered to a human subject of 61.2 kg (see Supporting Information, Table 2), the radiation exposures to WB and liver (≈1.5 kg) were calculated by considering W T and FN as follows: C compound of ≈100 nCi was dosed to a 70 kg human subject, a 25 μL plasma sample would be about 10 Modern. The formula (eq 2) can be used to estimate the amount of 14 C dose. For more complete estimation, the bioavailability and body distribution of the food component or nutrient should be considered (3).
RESULTS AND DISCUSSION
Calculating Human Radiation Exposure from 14 C-Nutrients. The dose of 14 C-nutrients and radiation exposures were estimated over the biological mean-life (τ biological ) ( Table 2 ). The 14 C-nutrients containing 36-101.5 nCi were orally ingested at breakfast by human subjects weighing 52-116 kg. Biological half-lives (t 1/2 ) of these nutrients ranged from 2.5 to 100 days.
Radiation exposure to WB ranged from 0.12 to 5.2 μSv, which was 4-170 times lower than that experienced during a 4 h flight (20 μSv) (28). In general, radiation exposure increased as the biological mean-life of nutrient increased and as the organ or tissue mass decreased. Assuming 100% of the body's stored 14 C-nutrients was housed in liver regardless of the W T and FN, then radiation exposure to a 1.5 kg liver was calculated to be ≈50 times higher than that to a 70 kg WB. If all of a 100 nCi 14 C-β-carotene dose was converted to 14 C-retinol and stored in the liver, the radiation exposure to liver was increased to a maximum 354 μSv ( Table 2) . Sequestration of 100% of the 14 C label in the liver represents the "worst case" scenario. By considering the W T and FN, radiation exposures to liver (Table 2 ) were calculated to range from 0.2 to 12.8 μSv, which was lower than that experienced during a 4 h flight at 37000 ft altitude (20 μSv). Although 14 C-retinol had a longer half-life (140 days), radiation exposure to liver from 14 C-retinol was calculated to be 12.8 μSv when the W T (0.04 in liver) and FN (0.9 in liver) were considered. Consequently, radiation exposure from dose with 100 nCi 14 C was equal to or less than that experienced from common/natural radiation (see Supporting Information, Table 3 ).
Radioactive isotopes emit energy depending on R-, β-, or γ-decay. People are exposed to various radiation sources during their lifetime, and the limit of annual radiation exposure differed between WB, organ, or tissue (see Supporting Information Table 3 ). 14 C emitted an electron for each β-decay, the average energy of which was 8.3 fJ/decay (3). Thus, the reference human (70 kg, ≈ 1.1 Modern, assumed 23% carbon content) was naturally/ constantly exposed to ≈1.7 nSv/h at the ambient where J/kg = Sv) (3). Deposition of the radiation energy from the administered 14 C-nutrient was neither complete nor constant throughout the human body during the study because the 14 C-nutrient was metabolized, stored, and eventually excreted. The radiation exposure from ingested 14 C-nutrients or food components can be calculated using an exponential elimination model as a function of time since dose, as long as the biological mean-lives of the 14 C-labeled nutrients were shorter than the expected human life span (3). Therefore, full dynamic/kinetic modeling was required for the more exact calculation of human radiation exposure. Furthermore, correction of radiation exposure due to radioisotope decay was not necessary when τ isotope was much longer than τ bio . In addition, considering W T and FN enabled more complete calculation than a prior calculation (3) of radiation exposure to individual organs and tissues. In the present study, radiation exposure to liver was 30-75 times lower when the W T and FN of each nutrient were considered (Table 2) . Finally, radiation exposures to WB and liver from all 14 C-nutrients (Table 2) were lower than natural/human-made radiation exposure. Dose Calculation for Optimal 14 C-AMS Measurement of 1 mg of C Size Samples. Table 3 summarizes the calculated and measured maximum 14 C levels in human plasma, feces, or urine samples that contained 1 mg of C. The physiological-based 14 C-nutrient study required a dose with the same or smaller amount of 14 C-nutrient relative to its RDA or AI. The ratio (mol/mol) of 14 C-nutrient to the RDA or AI was e1/1812 (17, 18, 20, 21) , which was even smaller than the microdosing level, 1/100 (25, 26) . The ratio (mol/mol) of 14 C-lutein to its AI ranged from 1/3 to 1/28 (19) , due to the low specific activity of 14 C-lutein ingested (Table 1) , and even this ratio (1/3 to 1/28) was suitable for physiological-based pharmacokinetics and ADME measurements (Table 1) . In general, the maximum 14 C level in feces and in urine was higher than the maximum 14 C level in plasma. Therefore, feces and urine samples containing >100 Modern usually needed to be diluted with tributyrin, which was devoid of 14 C. Thus, the levels of 14 C in the diluted feces and urine were within the optimal 14 C-AMS working range. Masses or volumes of the feces and of urine collections were difficult to control compared to those of human blood. Furthermore, feces and urine collections varied widely in their carbon content compared to human blood. Consequently, the Modern values of feces and urine were higher and more variable than those of human blood, due to the variable concentrations of carbon in feces/urines and the first-pass elimination of 14 C-nutrient in feces. Although maximum 14 C levels in feces and urine were variable depending on ADME, nutrient hydrophobicity, subject traits, etc., dosing of e100 nCi was suitable for 14 C-AMS, the optimal range of which was 0.01-100 Modern. In fact, determination of 14 C-dose amount for optimal 14 C-AMS measurement was difficult because that determination needed to consider the hydrophilic, hydrophobic, and bioavailability characteristics of nutrients, human body weight, and sensitivity of AMS. Most nutrients would be transferred, partitioned, or distributed among body organs (liver, gut, etc.), intracellular (21 L), interstitial (18 L), intravascular fluids (3 L), and WB water (42 L). If water-soluble compounds were distributed in WB water of 42 L, ≈100 nCi of 14 C would peak at about (21) , some feces and urine samples (18) (19) (20) (21) that were suspected to have high 14 C levels were diluted with a TRIB for optimal 14 C-AMS measurement (0.01-100 Modern range).
10 Modern in 25 μL of plasma (which contained 1 mg of C), even though the bioavailability of nutrients was variable. On the other hand, very hydrophobic compounds or compounds with e20% bioavailability required a larger dose of ≈200 nCi to study 14 C-nutrients with long biological half-life (3). Even though the administered doses ranged from 36 to 100 nCi in our four prior studies, by considering tissue weighting factor and fractional nutrient factor, the radiation exposures to WB (0.12-5.2 μSv) or to liver (0.2-3.4 μSv) were much lower than that from a 4 h aircraft flight (20 μSv). Furthermore, 14 C-doses of 36-100 nCi were measured in the range of 0.01-100 Modern in plasma, urine, and feces aliquots that contained 1 mg of C. All materials and samples from graphitization and 14 C-AMS measurement can be considered nonradioactive waste materials, at significant cost saving for disposal.
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